| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.37 | 4e-14 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |